Dumat-ol, Ramil A.

HRN: 21-24-31  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2023
CEFTRIAXONE 1G (VIAL)
01/31/2023
02/07/2023
IV
1g
Q8H
Prophylaxis For OR-plating L Humerus
Waiting Final Action 
02/01/2023
CEFTRIAXONE 1G (VIAL)
02/01/2023
02/08/2023
IV
2g
OD
Fracture
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: